medicine for non hodgkin lymphoma - Page 9 of 11

VINCRISTINE

VINCRISTINE is a Schedule H drug.

RITUXIMAB is a Schedule H drug.

NIVOLUMAB is a Schedule H drug.

MITOXANTRONE is a Schedule H drug.

IBRITUMOMAB TIUXETAN is a Schedule H drug.

CISPLATIN is a Schedule H drug.

BENDAMUSTINE is a Schedule G drug.

ZUMUSTIN 100MG INJ is a Schedule G drug. ZUMUSTIN 100MG INJ is composed of: BENDAMUSTINE (100.0 MG)

VINSTIN 1MG INJ is a Schedule H drug. VINSTIN 1MG INJ is composed of: VINCRISTINE (1.0 MG)

VINLON 1MG INJ is a Schedule H drug. VINLON 1MG INJ is composed of: VINCRISTINE (1.0 MG)